title: [Assessment of adherence to antiretroviral drugs in a municipality in southern Brazil].
abstract: The aim of this research is to assess predicting factors and adherence levels to antiretrovirals through self-report and the date of drug retrieval. It is a transversal study in which 67 patients were interviewed. Patients who used more than 90% of doses were considered to have complied with the treatment. Results of adherence were: self-reports (72.7%); calculated using dosage forgotten on the last day (70%); in three (76.1%) days; in seven (80.5%) days; and in fifteen (80.5%) days; calculated using the date of drug retrieval in a period of three (53.7%) months; and in six (47.8%) months. Variables significantly associated with adherence were: educational level, living with the family, refer good adherence, positive assessment of the antiretroviral therapy, a diagnosis of an opportunistic disease, NADIR greater than 200 cells/mm(3) and being in first-time treatment. To improve adherence rates individual and collective strategies should be elaborated taking into account factors which have been identified as negatively effecting adherence.
authors.affiliation: Curso de Farmácia e Medicina, Universidade do Sul de Santa Catarina, Tubarão, SC.
authors.forename: Carine Raquel
authors.initials: CR
authors.lastname: Blatt
authors.forename: Cecília Bathke
authors.initials: CB
authors.lastname: Citadin
authors.forename: Fernanda Gaspar de
authors.initials: FG
authors.lastname: Souza
authors.forename: Rogério Sobrosa de
authors.initials: RS
authors.lastname: Mello
authors.forename: Dayani
authors.initials: D
authors.lastname: Galato
mesh_terms: D000328:Adult; D000368:Aged; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001938:Brazil; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D055815:Young Adult; D016903:Drug Monitoring
chemical_list: D019380:Anti-HIV Agents